30) Duarte, A.F., et al., Are General Physicians Prepared for Struggling Skin Cancer?-Cross-Sectional Study. J Cancer Educ, 2018. 33(2): p. 321-324.
31) Zimmerlé, V., et al., [Recognition and initial management of melanoma by general practitioners: A survey in a rural French area with low medical density]. Presse Med, 2018. 47(4 Pt 1): p. e35-e42.
32) Garrido, A.Q., et al., Diagnosis of Cutaneous Melanoma: the Gap Between the Knowledge of General Practitioners and Dermatologists in a Brazilian Population. J Cancer Educ, 2020. 35(4): p. 819-825.
33) Ilyas, M., et al., The role of the ugly duckling sign in patient education. J Am Acad Dermatol, 2017. 77(6): p. 1088-1095.
34) Johansson, M., et al., Screening for reducing morbidity and mortality in malignant melanoma. Cochrane Database Syst Rev, 2019. 6(6): p. Cd012352.
35) Chia, A. and L. Trevena, A Systematic Review of Training to Improve Melanoma Diagnostic Skills in General Practitioners. J Cancer Educ, 2016. 31(4): p. 730-735.
36) Castro, L.G., et al., Guidelines of the Brazilian Dermatology Society for diagnosis, treatment and follow up of primary cutaneous melanoma--Part I. An Bras Dermatol, 2015. 90(6): p. 851-61.
37) Ferrante di Ruffano, L., et al., Computer-assisted diagnosis techniques (dermoscopy and spectroscopy-based) for diagnosing skin cancer in adults. Cochrane Database Syst Rev, 2018. 12(12): p. Cd013186.
38) Blundo, A., et al., Comparative Analysis of Diagnostic Techniques for Melanoma Detection: A Systematic Review of Diagnostic Test Accuracy Studies and Meta-Analysis. Front Med (Lausanne), 2021. 8: p. 637069.
39) Jones, O.T., et al., Dermoscopy for melanoma detection and triage in primary care: a systematic review. BMJ Open, 2019. 9(8): p. e027529.
40) Carli, P., et al., Improvement of malignant/benign ratio in excised melanocytic lesions in the "dermoscopy era": a retrospective study 1997-2001. Br J Dermatol, 2004. 150(4): p. 687-92.
41) Vestergaard, M.E., et al., Dermoscopy compared with naked eye examination for the diagnosis of primary melanoma: a meta-analysis of studies performed in a clinical setting. Br J Dermatol, 2008. 159(3): p. 669-76
42) Lallas, A., et al., Update on dermoscopy of Spitz/Reed naevi and management guidelines by the International Dermoscopy Society. BrJDermatol, 2017. 177(3): p. 645-655.
43) Bowling, J., et al., Dermoscopy key points: recommendations from the international dermoscopy society. Dermatology, 2007. 214(1): p. 3-5.
44) Soltani-Arabshahi, R., et al., Predictive value of biopsy specimens suspicious for melanoma: support for 6-mm criterion in the ABCD rule. J Am Acad Dermatol, 2015. 72(3): p. 412-8.
45) Deinlein T, Michor C, Hofmann-Wellenhof R, Schmid-Zalaudek K, Fink-Puches R. The importance of total-body photography and sequential digital dermatoscopy for monitoring patients at increased melanoma risk. J Dtsch Dermatol Ges. 2020;18(7):692-697. doi:10.1111/ddg.14158
46) Pampena, R., et al., A meta-analysis of nevus-associated melanoma: Prevalence and practical implications. J Am Acad Dermatol, 2017. 77(5): p. 938-945.e4.
47) Lallas, A., et al., The BRAAFF checklist: a new dermoscopic algorithm for diagnosing acral melanoma. Br J Dermatol, 2015. 173(4): p. 1041-9.
48) Pflugfelder, A., et al., Incisional biopsy and melanoma prognosis: Facts and controversies. Clin Dermatol, 2010. 28(3): p. 316-8.
49) Wheatley, K., et al., Surgical excision margins in primary cutaneous melanoma: A meta-analysis and Bayesian probability evaluation. Cancer Treat Rev, 2016. 42: p. 73-81.
50) Wheatley, K., et al., Reply to response to Wheatley et al., "Surgical excision margins in primary cutaneous melanoma: A meta-analysis and Bayesian probability evaluation" Cancer Treatment Reviews April 2016;45:76. Cancer Treat Rev, 2017. 55: p. 225-229.
51) Veronesi, U., et al., Thin stage I primary cutaneous malignant melanoma. Comparison of excision with margins of 1 or 3 cm. N Engl J Med, 1988. 318(18): p. 1159-62
52) Farberg, A.S. and D.S. Rigel, A comparison of current practice patterns of US dermatologists versus published guidelines for the biopsy, initial management, and follow up of patients with primary cutaneous melanoma. J Am Acad Dermatol, 2016. 75(6): p. 1193-1197.e1.
53) Weinstock, M.A., et al., Skin biopsy utilization and melanoma incidence among Medicare beneficiaries. Br J Dermatol, 2017. 176(4): p. 949-954.
54) Rayess, H.M., et al., A critical analysis of melanoma malpractice litigation: Should we biopsy everything? Laryngoscope, 2017. 127(1): p. 134-139.
55) Moscarella, E., et al., Intralesional (incision) biopsy for melanoma diagnosis: the rules and the exception. G Ital Dermatol Venereol, 2017. 152(6): p. 658-662.
56) Bolshinsky, V., et al., Frequency of residual melanoma in wide local excision (WLE) specimens after complete excisional biopsy. J Am Acad Dermatol, 2016. 74(1): p. 102-7.
57) Luk, P.P., et al., Punch biopsy of melanoma causing tumour cell implantation: another peril of utilising partial biopsies for melanocytic tumours. Australas J Dermatol, 2015. 56(3): p. 227-31.
58) Mills, J.K., et al., Effect of biopsy type on outcomes in the treatment of primary cutaneous melanoma. Am J Surg, 2013. 205(5): p. 585-90; discussion 590
59) Singal, A. and K. Bisherwal, Melanonychia: Etiology, Diagnosis, and Treatment. Indian Dermatol Online J, 2020. 11(1): p. 1-11
60) Carney, P.A., et al., Achieving consensus for the histopathologic diagnosis of melanocytic lesions: use of the modified Delphi method. JCutanPathol, 2016. 43(10): p. 830-7.